| # | Drug | Count |
|---|---|---|
| 0 | RITONAVIR | 18 |
| 1 | ATAZANAVIR | 10 |
| 2 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 10 |
| 3 | LOPINAVIR AND RITONAVIR | 9 |
| 4 | ABACAVIR SULFATE | 8 |
| 5 | RITONAVIR 100 MG | 8 |
| 6 | DARUNAVIR | 7 |
| 7 | LAMIVUDINE | 7 |
| 8 | LAMIVUDINE ORAL | 7 |
| 9 | ZIDOVUDINE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MARAVIROC | 3 | 0.0013 |
| 1 | RALTEGRAVIR | 5 | 0.0010 |
| 2 | ABACAVIR SULFATE | 8 | 0.0008 |
| 3 | ATAZANAVIR | 10 | 0.0007 |
| 4 | ZIDOVUDINE | 7 | 0.0007 |
| 5 | LOPINAVIR AND RITONAVIR | 9 | 0.0007 |
| 6 | RITONAVIR 100 MG | 8 | 0.0005 |
| 7 | MEGESTROL ACETATE | 2 | 0.0005 |
| 8 | DARUNAVIR | 7 | 0.0005 |
| 9 | EFAVIRENZ | 5 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 3 | 0.0013 |
| 1 | Protease Inhibitor [EPC] | 27 | 0.0006 |
| 2 | Cytochrome P450 3A Inhibitor [EPC] | 27 | 0.0004 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 15 | 0.0003 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 7 | 0.0003 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 30 | 0.0003 |
| 6 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 7 | Sulfone [EPC] | 1 | 0.0001 |
| 8 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |